retatrutide nejm 2023 obesity trial ly3437943 Phase 2 of for Want to learn more about

What Happens: GLP-1 medications cross the blood-brain barrier Activate receptors in appetite control regions Reduce hunger signals Increase satiety (feeling of fullness) Decrease reward response to food Reduce obsessive thoughts about food What You Experience: Less frequent hunger Feel satisfied with smaller portions Dont think about food constantly Reduced cravings for specific foods Easier to say no to unnecessary eating This is the primary mechanismyou naturally eat less because you genuinely want less food

10.1016/S0959-440X(96)80036-4 9 FarnoodianM.HalbachC.SlingerC.PattnaikB

This necessitates being able to recover quickly from training sessions

Akagi T, Kaneda M, Ishii K, Hashikawa T

When kids develop Type 2 diabetes, its a sign that something is really, really wrong with their metabolism and/or physiology, and how their body is functioning